An issue was discovered in Roche Accu-Chek Inform II Instrument before 03.06.00 (Serial number below 14000) and 04.x before 04.03.00 (Seria…

published 2018-11-20 7 y ago modified 2026-06-17 4 mo ago also EUVD-2018-10284

cvss: 7.4; version 3.0, NVD
cisa kev: Not listed; not in CISA's catalog
epss: 0.6%; EPSS 0.6% chance of exploitation in 30 days, percentile 48%
public exploits: 0; none known

An issue was discovered in Roche Accu-Chek Inform II Instrument before 03.06.00 (Serial number below 14000) and 04.x before 04.03.00 (Serial Number above 14000), CoaguChek Pro II before 04.03.00, and cobas h 232 before 04.00.04 (Serial number above KQ0400000 or KS0400000). Improper access control allows attackers in the adjacent network to change the instrument configuration.

Patch / fix

fixed in 3

roche accu-chek_inform_ii_firmware 03.06.00, 04.03.00
roche cobas_h_232_firmware 04.00.04
roche coaguchek_pro_ii_firmware 04.03.00

Vendor advisories

What the vendors themselves say about their products: affected, fixed or not affected, and what to do.

cisa ICSMA-18-310-01 updated 2018-11-08 cvss 8.3

Roche Diagnostics Point of Care Handheld Medical Devices (Update A)

Roche Diagnostics Point of Care handheld medical devices Accu-Chek Inform II, CoaguChek Pro II, CoaguChek XS Plus, CoaguChek XS Pro
affected: vendor fix roche.com

From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf

Exploit prediction

0.58% chance of exploitation in the next 30 days, higher than 48% of all scored CVEs (FIRST EPSS, 2026-11-08).

CVSS scores

assigned by	version	score	vector
NVD	3.0	7.4	CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:C/C:N/I:H/A:N
NVD	2.0	3.3	AV:A/AC:L/Au:N/C:N/I:P/A:N

References

ics-cert.us-cert.gov /advisories/ICSMA-18-310-01
mitigation, third-party-advisory, us-government-resource
securityfocus.com /bid/105843
vdb-entry, third-party-advisory

Sources

CVE List CVE-2018-18564
NVD CVE-2018-18564

Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

Summary